Dr. Chris Smyth, president of ICON Biotech, discusses emerging trends in the biotech space.
Chris Smyth
Advertisement
Articles by Chris Smyth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
2
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
3
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
4
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
5